Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 8/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 8/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.42 |
| ▸ | SNCA | P37840 | 1/20 | 0.42 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.42 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4854982 | 0.90 | KDM4E (0.47) | KDM4ECYP1A1CYP1B1PTPN1DPP4 | |
| SCHEMBL4847832 | 0.87 | ABCG2 (0.46) | KDM4EPTPN1ABCG2DPP4CAPN1 | |
| SCHEMBL4849762 | 0.85 | KDM4E (0.52) | KDM4ECYP1A1CYP1B1PTPN1ABCG2 | |
| SCHEMBL4847755 | 0.83 | TNFRSF1A (0.46) | PTPN1ABCG2CAPN1SNCATUBB1 | |
| SCHEMBL4847397 | 0.83 | LMNA (0.49) | KDM4ECYP1A1CYP1B1PTPN1ABCG2 | |
| SCHEMBL4852536 | 0.82 | TUBB1 (0.53) | KDM4EABCG2TUBB1 | |
| SCHEMBL4853707 | 0.82 | TUBB1 (0.53) | KDM4EABCG2TUBB1 | |
| SCHEMBL4855894 | 0.81 | KDM4E (0.48) | KDM4ECYP1A1CYP1B1ABCG2TUBB1 | |
| SCHEMBL4847380 | 0.78 | KDM4E (0.45) | KDM4ECYP1A1CYP1B1ABCG2 | |
| SCHEMBL4848181 | 0.78 | KDM4E (0.45) | KDM4ECYP1A1CYP1B1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050227990-A1 | Aminoalkoxy-functional chalcones | LICA PHARMACEUTICALS A/S (DK) | 2005-10-13 | — | — | US | claimed |
| US-7423181-B2 | in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone | LICA PHARMACEUTICALS A/S (DK) | 2008-09-09 | — | — | US | disclosed |
| US-20050227990-A1 | Aminoalkoxy-functional chalcones | LICA PHARMACEUTICALS A/S (DK) | 2005-10-13 | — | — | US | disclosed |